This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by WALKER, P. Articles by DUPONT, A. Search for Related Content PubMed PubMed Citation Articles by WALKER, P. Articles by DUPONT, A.

The Development of the Hypothalamo-Pituitary Axis in the Neonatal Rat: Hypothalamic Somatostatin and Pituitary and Serum Growth Hormone Concentrations

Laboratoire de Recherches en Endocrinologie et Metabolisme, Le Centre Hospitaller de I'Universite Laval Quebec, Canada

Reprint requests to: J. H. Dussault, M.D., M.Sc., Laboratoire de Recherches en Endocrinologie et Metabolisme, Le Centre Hospitalier de l'Université Laval, 2705, boul. Laurier, Quebec G1V 4G2, Canada.

Abstract

Using a specific radioimmunoassay technique for somatostatin (GHRIH), we have studied the ontogenesis of hypothalamic GHRIH in relation to pituitary and serum GH concentrations in immature rats. Hypothalamic GHRIH concentration rose from minimal levels of 4.5 ± 0.2 pg/µg protein (mean ± SEM) at 2 days to peak concentrations of 40.6 ±4.1 pg/µg protein at 28 days followed by a progressive decline toward 50 days (7.0 ± 0.8 pg/µg protein). Pituitary GH concentration attained peak prepuberal values of 203.5 ± 22.8 ng/µg protein at 16 days with a further marked rise after puberty. Serum GH concentration was elevated at 2 days (53.3 ± 5.7 ng/µl) and declined progressively to 5.9 ± 1.5 ng/µl at 13 days. There was a highly significant inverse correlation between hypothalamic GHRIH and serum GH concentrations (r = -0.743, P < 0.005). These data indicate that the hypothalamic regulatory mechanism for pituitary GH release develops during the neonatal period of the rat and suggest that GHRIH may play an important physiological role in this process.

Footnotes

Supported in part by Grant no. MA-5730 of the Medical Research Council of Canada.

Received November 1, 1976.

This article has been cited by other articles:

				G. Tulipano, D. Soldi, M. Bagnasco, M. D. Culler, J. E. Taylor, D. Cocchi, and A. Giustina Characterization of New Selective Somatostatin Receptor Subtype-2 (sst2) Antagonists, BIM-23627 and BIM-23454. Effects of BIM-23627 on GH Release in Anesthetized Male Rats after Short-Term High-Dose Dexamethasone Treatment Endocrinology, April 1, 2002; 143(4): 1218 - 1224. [Abstract] [Full Text] [PDF]

				C. Phornphutkul, G. P. Frick, H. M. Goodman, S. A. Berry, and P. A. Gruppuso Hepatic Growth Hormone Signaling in the Late Gestation Fetal Rat Endocrinology, October 1, 2000; 141(10): 3527 - 3533. [Abstract] [Full Text] [PDF]

				D. K. Reed, A. I. Korytko, R. W. Hipkin, W. B. Wehrenberg, A. Schonbrunn, and L. Cuttler Pituitary Somatostatin Receptor (sst)1-5 Expression during Rat Development: Age-Dependent Expression of sst2 Endocrinology, October 1, 1999; 140(10): 4739 - 4744. [Abstract] [Full Text]

				E. E. Muller, V. Locatelli, and D. Cocchi Neuroendocrine Control of Growth Hormone Secretion Physiol Rev, April 1, 1999; 79(2): 511 - 607. [Abstract] [Full Text] [PDF]

				S. Ramos, L. Goya, C. Alvarez, and A. M. Pascual-Leone Mechanism of Hypothyroidism Action on Insulin-Like Growth Factor-I and -II from Neonatal to Adult Rats: Insulin Mediates Thyroid Hormone Effects in the Neonatal Period Endocrinology, December 1, 1998; 139(12): 4782 - 4792. [Abstract] [Full Text] [PDF]

				S. X. Simonian, H. E. Murray, G. E. Gillies, and A. E. Herbison Estrogen-Dependent Ontogeny of Sex Differences in Somatostatin Neurons of the Hypothalamic Periventricular Nucleus Endocrinology, March 1, 1998; 139(3): 1420 - 1428. [Abstract] [Full Text] [PDF]